| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 4.35e-14 | 27 | 38 | 7 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 5.79e-14 | 28 | 38 | 7 | GO:0099602 | |
| GeneOntologyMolecularFunction | protein kinase binding | SPDYE1 SPDYE8 SPDYE21 SPDYE11 SPDYE17 SPDYE5 SPDYE18 SPDYE10 SPDYE12 SPDYE15 SPDYE2B SPDYE6 SPDYE14 SPDYE16 SPDYE2 | 2.18e-11 | 873 | 38 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | SPDYE1 SPDYE8 SPDYE21 SPDYE11 SPDYE17 SPDYE5 SPDYE18 SPDYE10 SPDYE12 SPDYE15 SPDYE2B SPDYE6 SPDYE14 SPDYE16 SPDYE2 | 9.48e-11 | 969 | 38 | 15 | GO:0019900 |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 1.41e-04 | 616 | 38 | 7 | GO:0030545 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 6.14e-13 | 25 | 28 | 6 | GO:0045737 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 1.30e-12 | 28 | 28 | 6 | GO:1904031 | |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein serine/threonine kinase activity | 3.01e-09 | 96 | 28 | 6 | GO:0000079 | |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein kinase activity | 3.86e-09 | 100 | 28 | 6 | GO:1904029 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 1.97e-07 | 193 | 28 | 6 | GO:0071902 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 6.29e-06 | 350 | 28 | 6 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | 7.15e-06 | 358 | 28 | 6 | GO:0071900 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.44e-05 | 405 | 28 | 6 | GO:0033674 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 1.48e-05 | 407 | 28 | 6 | GO:0045787 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 2.81e-05 | 686 | 28 | 7 | GO:0043549 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 4.21e-05 | 490 | 28 | 6 | GO:0051347 | |
| GeneOntologyBiologicalProcess | embryonic process involved in female pregnancy | 7.94e-05 | 10 | 28 | 2 | GO:0060136 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 8.06e-05 | 810 | 28 | 7 | GO:0051338 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 1.42e-04 | 611 | 28 | 6 | GO:0045859 | |
| GeneOntologyBiologicalProcess | myeloid progenitor cell differentiation | 1.60e-04 | 14 | 28 | 2 | GO:0002318 | |
| GeneOntologyBiologicalProcess | enucleate erythrocyte differentiation | 2.11e-04 | 16 | 28 | 2 | GO:0043353 | |
| GeneOntologyBiologicalProcess | folic acid metabolic process | 2.68e-04 | 18 | 28 | 2 | GO:0046655 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | 3.56e-04 | 724 | 28 | 6 | GO:0001934 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 5.30e-04 | 780 | 28 | 6 | GO:0042327 | |
| GeneOntologyBiologicalProcess | trophectodermal cell differentiation | 5.66e-04 | 26 | 28 | 2 | GO:0001829 | |
| GeneOntologyBiologicalProcess | definitive hemopoiesis | 6.11e-04 | 27 | 28 | 2 | GO:0060216 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 8.60e-04 | 32 | 28 | 2 | GO:0048596 | |
| GeneOntologyBiologicalProcess | folic acid-containing compound metabolic process | 9.71e-04 | 34 | 28 | 2 | GO:0006760 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | 9.91e-04 | 879 | 28 | 6 | GO:0045937 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | 9.91e-04 | 879 | 28 | 6 | GO:0010562 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | 1.01e-03 | 1226 | 28 | 7 | GO:0042325 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 1.17e-03 | 1256 | 28 | 7 | GO:0051726 | |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 1.21e-03 | 38 | 28 | 2 | GO:0048048 | |
| GeneOntologyBiologicalProcess | pteridine-containing compound metabolic process | 1.34e-03 | 40 | 28 | 2 | GO:0042558 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | 1.38e-03 | 937 | 28 | 6 | GO:0031401 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 1.70e-03 | 45 | 28 | 2 | GO:0031076 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | 2.21e-03 | 1028 | 28 | 6 | GO:0043085 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | 2.38e-03 | 1421 | 28 | 7 | GO:0019220 | |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | 2.40e-03 | 1423 | 28 | 7 | GO:0051174 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | 2.47e-03 | 1430 | 28 | 7 | GO:0044093 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | 2.75e-03 | 1458 | 28 | 7 | GO:0051247 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | 3.09e-03 | 1488 | 28 | 7 | GO:0031399 | |
| Domain | Spy1 | 4.26e-18 | 11 | 30 | 7 | PF11357 | |
| Domain | Speedy | 4.26e-18 | 11 | 30 | 7 | IPR020984 | |
| Domain | Sp1_fam | 4.45e-07 | 10 | 30 | 3 | IPR030450 | |
| Domain | MATH | 1.63e-04 | 12 | 30 | 2 | SM00061 | |
| Domain | MATH | 1.63e-04 | 12 | 30 | 2 | PF00917 | |
| Domain | MATH/TRAF_dom | 1.63e-04 | 12 | 30 | 2 | IPR002083 | |
| Domain | MATH | 1.63e-04 | 12 | 30 | 2 | PS50144 | |
| Domain | - | 2.24e-04 | 14 | 30 | 2 | 2.60.210.10 | |
| Domain | TRAF-like | 6.73e-04 | 24 | 30 | 2 | IPR008974 | |
| Domain | BTB | 1.87e-02 | 131 | 30 | 2 | PF00651 | |
| Pathway | WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE | 1.21e-05 | 5 | 16 | 2 | M45554 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 1.81e-05 | 6 | 16 | 2 | MM1564 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 1.81e-05 | 6 | 16 | 2 | M22047 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 2.53e-05 | 7 | 16 | 2 | MM1541 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 3.37e-05 | 8 | 16 | 2 | M22015 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 1.01e-04 | 82 | 16 | 3 | M2 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.83e-04 | 18 | 16 | 2 | M3430 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.83e-04 | 18 | 16 | 2 | MM1385 | |
| Pathway | WP_MITOCHONDRIAL_GENE_EXPRESSION | 2.04e-04 | 19 | 16 | 2 | M39544 | |
| Pathway | WP_MITOCHONDRIAL_GENE_EXPRESSION | 2.04e-04 | 19 | 16 | 2 | MM15973 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 3.86e-04 | 26 | 16 | 2 | MM14878 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 4.58e-04 | 137 | 16 | 3 | MM15182 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 5.97e-04 | 150 | 16 | 3 | M27440 | |
| Pathway | WP_ONECARBON_METABOLISM | 6.63e-04 | 34 | 16 | 2 | MM15859 | |
| Pathway | REACTOME_AGGREPHAGY | 7.44e-04 | 36 | 16 | 2 | MM15669 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 7.44e-04 | 36 | 16 | 2 | M633 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 9.65e-04 | 41 | 16 | 2 | MM14876 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 1.06e-03 | 43 | 16 | 2 | M39706 | |
| Pathway | REACTOME_AGGREPHAGY | 1.11e-03 | 44 | 16 | 2 | M29830 | |
| Pathway | WP_SELENIUM_METABOLISM_SELENOPROTEINS | 1.16e-03 | 45 | 16 | 2 | MM15877 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 1.21e-03 | 46 | 16 | 2 | MM15949 | |
| Pathway | WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS | 1.27e-03 | 47 | 16 | 2 | M48301 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 1.49e-03 | 51 | 16 | 2 | M665 | |
| Pathway | PID_MYC_REPRESS_PATHWAY | 2.27e-03 | 63 | 16 | 2 | M254 | |
| Pathway | PID_TELOMERASE_PATHWAY | 2.56e-03 | 67 | 16 | 2 | M105 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 3.03e-03 | 73 | 16 | 2 | M39401 | |
| Pathway | PID_E2F_PATHWAY | 3.03e-03 | 73 | 16 | 2 | M40 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 3.03e-03 | 73 | 16 | 2 | MM15672 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 3.19e-03 | 75 | 16 | 2 | M39568 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.36e-03 | 77 | 16 | 2 | MM14670 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 1.77e-18 | 13 | 38 | 7 | 15611625 | |
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 2.00e-17 | 17 | 38 | 7 | 15574121 | |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 9.42e-17 | 9 | 38 | 6 | 36272447 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 22763696 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 23540600 | ||
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 26967243 | ||
| Pubmed | Curcumin decreases specificity protein expression in bladder cancer cells. | 1.20e-09 | 3 | 38 | 3 | 18593936 | |
| Pubmed | 1.20e-09 | 3 | 38 | 3 | 21919647 | ||
| Pubmed | Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. | 1.20e-09 | 3 | 38 | 3 | 11532028 | |
| Pubmed | Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. | 1.20e-09 | 3 | 38 | 3 | 7559627 | |
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 15781457 | ||
| Pubmed | 4.81e-09 | 4 | 38 | 3 | 27889927 | ||
| Pubmed | 1.20e-08 | 5 | 38 | 3 | 12560508 | ||
| Pubmed | 1.20e-08 | 5 | 38 | 3 | 20538607 | ||
| Pubmed | 1.20e-08 | 5 | 38 | 3 | 10547281 | ||
| Pubmed | 2.40e-08 | 6 | 38 | 3 | 16201967 | ||
| Pubmed | 4.20e-08 | 7 | 38 | 3 | 12004059 | ||
| Pubmed | 4.52e-07 | 441 | 38 | 7 | 12853948 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 10825178 | ||
| Pubmed | HPV8 activates cellular gene expression mainly through Sp1/3 binding sites. | 1.16e-06 | 2 | 38 | 2 | 31299490 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 19437621 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 16488127 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 7565695 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 16740475 | ||
| Pubmed | Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. | 1.16e-06 | 2 | 38 | 2 | 8845379 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 25175639 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 14766015 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 25538045 | ||
| Pubmed | Established and novel Cdk/cyclin complexes regulating the cell cycle and development. | 1.16e-06 | 2 | 38 | 2 | 21630153 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 20399258 | ||
| Pubmed | Transcriptional control of human CD2AP expression: the role of Sp1 and Sp3. | 1.16e-06 | 2 | 38 | 2 | 21604172 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 1454515 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 21248046 | ||
| Pubmed | Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors. | 1.16e-06 | 2 | 38 | 2 | 31164147 | |
| Pubmed | Sp1 and Sp3 activate transcription of the human dopamine transporter gene. | 1.16e-06 | 2 | 38 | 2 | 15816870 | |
| Pubmed | Sp family transcription factors regulate expression of rat D2 dopamine receptor gene. | 1.16e-06 | 2 | 38 | 2 | 9628590 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 17681019 | ||
| Pubmed | Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice. | 1.16e-06 | 2 | 38 | 2 | 37735515 | |
| Pubmed | The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat cells. | 1.16e-06 | 2 | 38 | 2 | 14608051 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 23941741 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 26807725 | ||
| Pubmed | An Sp1/Sp3 binding polymorphism confers methylation protection. | 1.16e-06 | 2 | 38 | 2 | 18725933 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15951564 | ||
| Pubmed | Differentiation-dependent and cell-specific regulation of the hIGFBP-1 gene in human endometrium. | 1.16e-06 | 2 | 38 | 2 | 9329821 | |
| Pubmed | Roadkill attenuates Hedgehog responses through degradation of Cubitus interruptus. | 1.16e-06 | 2 | 38 | 2 | 16651542 | |
| Pubmed | Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. | 1.16e-06 | 2 | 38 | 2 | 22464952 | |
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 2.72e-06 | 25 | 38 | 3 | 15820306 | |
| Pubmed | Sp1 and Sp3 Are important regulators of AP-2gamma gene transcription. | 3.48e-06 | 3 | 38 | 2 | 12801994 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15821099 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 17652716 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 12730302 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18417714 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 16339759 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 12694199 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 26162987 | ||
| Pubmed | Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. | 3.48e-06 | 3 | 38 | 2 | 14701757 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15118068 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 16677608 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15111490 | ||
| Pubmed | Modulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors. | 3.48e-06 | 3 | 38 | 2 | 17317039 | |
| Pubmed | Sp1 and Sp3 mediate basal and serum-induced expression of human CENP-W. | 3.48e-06 | 3 | 38 | 2 | 20180024 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11850421 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18314536 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 12855685 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15297147 | ||
| Pubmed | Accessible chromatin structure permits factors Sp1 and Sp3 to regulate human TGFBI gene expression. | 3.48e-06 | 3 | 38 | 2 | 21554857 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15451065 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18790003 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 30561605 | ||
| Pubmed | Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. | 3.48e-06 | 3 | 38 | 2 | 11274368 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 12378384 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15466927 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 12509426 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 36759621 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 16052479 | ||
| Pubmed | Sp1/3 and NF-1 mediate basal transcription of the human P2X1 gene in megakaryoblastic MEG-01 cells. | 3.48e-06 | 3 | 38 | 2 | 16529657 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 24315822 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11237613 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 17540780 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 16807381 | ||
| Pubmed | Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence. | 3.48e-06 | 3 | 38 | 2 | 23028678 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19306294 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15247906 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15482850 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 16760259 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15777284 | ||
| Pubmed | Involvement of Sp1/Sp3 in the activation of the GATA-1 erythroid promoter in K562 cells. | 3.48e-06 | 3 | 38 | 2 | 18195733 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 10816575 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 31863909 | ||
| Pubmed | Transcriptional regulation of the mouse gene encoding the alpha-4 subunit of the GABAA receptor. | 3.48e-06 | 3 | 38 | 2 | 15265862 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 20091743 | ||
| Pubmed | Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors. | 3.48e-06 | 3 | 38 | 2 | 23523134 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 26431879 | ||
| Pubmed | Structural and functional characterization of the mouse tescalcin promoter. | 3.48e-06 | 3 | 38 | 2 | 20540995 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 22682030 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 17906119 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 24850855 | ||
| Pubmed | HIV-1 Tat regulates the SOD2 basal promoter by altering Sp1/Sp3 binding activity. | 3.48e-06 | 3 | 38 | 2 | 15706661 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 16671893 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 27060138 | ||
| Interaction | TNFSF10 interactions | 1.36e-05 | 35 | 27 | 3 | int:TNFSF10 | |
| Interaction | SP4 interactions | 3.13e-05 | 46 | 27 | 3 | int:SP4 | |
| Interaction | NKX3-1 interactions | 4.54e-05 | 52 | 27 | 3 | int:NKX3-1 | |
| Interaction | DEAF1 interactions | 8.46e-05 | 64 | 27 | 3 | int:DEAF1 | |
| Interaction | RBBP4 interactions | 9.15e-05 | 573 | 27 | 6 | int:RBBP4 | |
| Interaction | VEGFA interactions | 9.28e-05 | 66 | 27 | 3 | int:VEGFA | |
| Interaction | SP1 interactions | 1.10e-04 | 365 | 27 | 5 | int:SP1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE8 SPDYE21 SPDYE9 SPDYE11 SPDYE17 SPDYE5 SPDYE18 SPDYE10 SPDYE13 SPDYE12 SPDYE15 SPDYE14 SPDYE16 | 8.26e-20 | 271 | 40 | 13 | chr7q11 |
| Cytoband | 7q11.23 | 2.75e-10 | 97 | 40 | 6 | 7q11.23 | |
| Cytoband | 7q22.1 | 1.34e-04 | 113 | 40 | 3 | 7q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 9.29e-04 | 219 | 40 | 3 | chr7q22 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 2.18e-18 | 12 | 24 | 7 | 756 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.72e-07 | 9 | 24 | 3 | 755 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.35e-02 | 134 | 24 | 2 | 861 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | SPDYE1 TUBB6 SPOP SPDYE5 SULT4A1 SPDYE2B SPDYE6 TUSC3 SPDYE16 SPDYE2 | 1.35e-06 | 1198 | 33 | 10 | MM1062 |
| Computational | Neighborhood of TNFRSF25 | 4.08e-04 | 30 | 11 | 2 | CAR_TNFRSF25 | |
| Drug | SP 0 | 2.46e-07 | 10 | 30 | 3 | CID002742752 | |
| Drug | hyperoside | 4.10e-06 | 24 | 30 | 3 | ctd:C021304 | |
| Drug | ADP-ribosylarginine | 4.66e-06 | 25 | 30 | 3 | CID000126311 | |
| Drug | homocysteic acid | 5.03e-06 | 3 | 30 | 2 | ctd:C007956 | |
| Drug | S-Nitrosoglutathione | 1.20e-05 | 34 | 30 | 3 | ctd:D026422 | |
| Drug | poly(tetramethylene adipate | 1.67e-05 | 5 | 30 | 2 | CID000032794 | |
| Drug | elemicin | 1.67e-05 | 5 | 30 | 2 | CID000010248 | |
| Drug | 3-(2-carboxyindol-3-yl)propionic acid | 2.46e-05 | 43 | 30 | 3 | CID000169313 | |
| Drug | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane | 9.16e-05 | 11 | 30 | 2 | ctd:C492909 | |
| Disease | Male sterility | 8.21e-04 | 48 | 26 | 2 | C0917731 | |
| Disease | Male infertility | 8.21e-04 | 48 | 26 | 2 | C0021364 | |
| Disease | Subfertility, Male | 8.21e-04 | 48 | 26 | 2 | C0848676 | |
| Disease | pancreatic cancer (is_implicated_in) | 4.37e-03 | 112 | 26 | 2 | DOID:1793 (is_implicated_in) | |
| Disease | mean reticulocyte volume | 4.96e-03 | 799 | 26 | 4 | EFO_0010701 | |
| Disease | Schizophrenia | 7.05e-03 | 883 | 26 | 4 | C0036341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NALRRCFFWRFMFYG | 71 | P13569 | |
| FFWRLCRTFGKIFTN | 861 | Q9P260 | |
| HRGSFCRSWFNMLDL | 931 | O60840 | |
| FGAMWLFFGCRHKDR | 571 | Q9UBK8 | |
| MSLYCGIACRRKFFW | 1 | Q86X67 | |
| RWIFGKFFCRVSAMF | 146 | Q9BZJ6 | |
| MGCSWRKTLSFFLVF | 1 | Q96A99 | |
| GWMRMISFIRSFCKY | 791 | A5PLK6 | |
| PFICNWMFCGKRFTR | 676 | Q02446 | |
| FCWTLFVYTKGNFRM | 176 | P28749 | |
| RFHFFCSMRCRAWVS | 226 | P0DUX0 | |
| RFHFFCSMRCRAWVS | 226 | P0DTA3 | |
| RFHFFCSMRCRAWVS | 226 | P0DUD1 | |
| FMCTWSYCGKRFTRS | 656 | P08047 | |
| KRRFHFFCSMSCRAW | 361 | A6NHP3 | |
| CFMFSIWRFAWRKSI | 206 | Q6ZRR5 | |
| WRYSSAFCNKLFFSM | 116 | Q13454 | |
| FCRRFMNDKLGYGSW | 161 | Q9BR01 | |
| SAMFRRKAFLHWFTG | 386 | Q9BUF5 | |
| ASRGWFMRFKERSHF | 131 | Q96MW7 | |
| RFHFFCSMRCRAWVS | 226 | P0DUX1 | |
| RFHFFCSMRCRAWVS | 226 | A0A494C0Z2 | |
| RFHFFCSMRCRAWVS | 226 | P0DUD3 | |
| RFHFFCSMRCRAWVS | 226 | P0DUD4 | |
| KLRFQFFCSMSGRAW | 271 | A6NNV3 | |
| RFHFFCSMRCRAWVS | 226 | P0DUD2 | |
| KLRFQFFCSMSGRAW | 311 | P0DV79 | |
| KFSYMWTINNFSFCR | 31 | Q6IQ16 | |
| KLRFQFFCSMSGRAW | 361 | A0A494C086 | |
| KFSYMWTINNFSFCR | 31 | O43791 | |
| KRRFHFFCSMSCRAW | 361 | Q495Y8 | |
| KRRFQFFCSMSGRAW | 361 | A6NIY4 | |
| KRRFHFFCSMSCRAW | 361 | P0CI01 | |
| FVCNWMYCGKRFTRS | 651 | Q02447 | |
| RRFHFFCSMSCRAWV | 296 | Q8NFV5 | |
| NNFLFGSRCWMTRFS | 31 | Q99551 | |
| MKRCSFLWAYAAQLA | 186 | Q8N806 | |
| RFQFFCSMSGRAWVS | 251 | A6NJR5 | |
| RFHFFCSMRCRAWVS | 226 | A0A494C191 | |
| FFMKGNCTWGMNCRF | 226 | Q86VM9 | |
| ASFMSFGVKRRWFAL | 66 | Q96IK0 |